After Metformin: The Newest Oral Antidiabetic Therapies and Cardiovascular Safety – MOC Section 1
CAN-eng
$0
gratuit
Cardiovascular, Diabetes, Endocrinology
1 Credits
Description du cours
Détails du cours
Date d'expiration : 2017-11-10
Faculté
Accréditation
Objectif(s) d'apprentissage
- Describe the newest classes of oral antidiabetic therapy available in Canada and their role in the management of type 2 diabetes.
- Review the evidence for cardiovascular safety of the newest oral antidiabetic therapies.
- Examine the safety considerations when selecting an oral agent for the management of type 2 diabetes in patients with cardiovascular disease.